misonidazole has been researched along with amifostine anhydrous in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (91.67) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conger, AD; Pratt, NE; Sinesi, M; Sodicoff, M; Trepper, P | 1 |
| Guttenberger, R; Hunter, NR; Milas, L | 1 |
| Bodó, K; Dám, AM; Gazsó, LG | 1 |
| Chapman, JD; Kanclerz, A | 1 |
| Brown, JM | 1 |
| Nakano, Y | 1 |
| Ebe, K | 1 |
| Chu, F; Hilaris, BS; Kim, JH; Nori, D | 1 |
| Durand, RE | 1 |
| Denekamp, J; Rojas, A; Williams, MV | 1 |
| Phillips, TL | 1 |
| Twentyman, PR | 1 |
| Brady, LW; Phillips, TL; Wasserman, TH | 1 |
| Grigsby, P; Maruyama, Y | 1 |
| Denekamp, J; Rojas, A; Stewart, FA | 2 |
| McNally, NJ | 1 |
| Hunter, N; Ito, H; Milas, L | 1 |
| Beach, JL; Grigsby, PW; Mendiondo, OA | 1 |
| Begg, AC; Terry, NH | 1 |
| Denekamp, J; Rojas, A | 1 |
| Tsukiyama, I | 1 |
| Denekamp, J; Williams, MV | 1 |
| Kehrberg, G; Moldenhauer, H; Rose, H; Saul, G; Wolf, G | 1 |
4 review(s) available for misonidazole and amifostine anhydrous
| Article | Year |
|---|---|
Sensitizers and protectors in radiotherapy.
Topics: Amifostine; Animals; Aziridines; Clinical Trials as Topic; Drug Evaluation; Etanidazole; Glutathione; Humans; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy | 1985 |
Sensitizers and protectors in clinical oncology.
Topics: Alkylating Agents; Amifostine; Animals; Drug Synergism; Humans; Mice; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1981 |
The potential for radiation sensitizers and radiation protectors combined with radiation therapy in gynecologic cancer.
Topics: Amifostine; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Genital Neoplasms, Female; Humans; Misonidazole; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Random Allocation | 1981 |
[Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
Topics: Amifostine; Animals; Central Nervous System Diseases; Dogs; Humans; Hyperthermia, Induced; In Vitro Techniques; Intestines; Lymphocytes; Metronidazole; Mice; Misonidazole; Neoplasms; Neoplasms, Experimental; Nerve Tissue; Nitro Compounds; Oxygen; Radiation Dosage; Radiation-Protective Agents; Radiation-Sensitizing Agents; Rats | 1983 |
3 trial(s) available for misonidazole and amifostine anhydrous
| Article | Year |
|---|---|
Sensitizers and protectors in radiotherapy.
Topics: Amifostine; Animals; Aziridines; Clinical Trials as Topic; Drug Evaluation; Etanidazole; Glutathione; Humans; Misonidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy | 1985 |
Radiosensitizers and protectors.
Topics: Amifostine; Animals; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Humans; Metronidazole; Misonidazole; Neoplasms; Oxygen; Pyrimidines; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1984 |
The potential for radiation sensitizers and radiation protectors combined with radiation therapy in gynecologic cancer.
Topics: Amifostine; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Genital Neoplasms, Female; Humans; Misonidazole; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents; Random Allocation | 1981 |
19 other study(ies) available for misonidazole and amifostine anhydrous
| Article | Year |
|---|---|
Chemoradioprotection of the rat parotid gland by combined use of WR-2721 and Ro-07-0582.
Topics: Amifostine; Animals; Dose-Response Relationship, Radiation; Drug Combinations; Female; Misonidazole; Nitroimidazoles; Organ Size; Parotid Gland; Radiation-Protective Agents; Rats; Time Factors; X-Rays | 1979 |
Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
Topics: Amifostine; Animals; Contracture; Depression, Chemical; Hair; Hindlimb; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Radiation-Induced; Stimulation, Chemical | 1992 |
Radiation response of E. coli after combined treatment with misonidazole and WR-2721 at various oxygen concentrations.
Topics: Amifostine; Escherichia coli; Misonidazole; Oxidation-Reduction; Oxygen; Radiation Tolerance; Radiobiology | 1990 |
Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Topics: Amifostine; Animals; Etanidazole; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Misonidazole; Neoplasm Metastasis; Neoplasms, Experimental; Nitroimidazoles; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1988 |
[Effect of combined radiotherapy, hyperthermia, radioprotective agent and hypoxic cell sensitizer on mice testis--testicular weight as indicator of the combined effect].
Topics: Amifostine; Animals; Combined Modality Therapy; Hyperthermia, Induced; Male; Mice; Misonidazole; Neoplasms, Experimental; Organ Size; Organothiophosphorus Compounds; Radiation-Protective Agents; Testis | 1985 |
[Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].
Topics: Amifostine; Animals; Carcinoma, Ehrlich Tumor; Cell Survival; Cells, Cultured; Mice; Mice, Inbred ICR; Misonidazole; Organothiophosphorus Compounds; Radiation-Protective Agents | 1987 |
Roles of thiols in cellular radiosensitivity.
Topics: Amifostine; Animals; Buthionine Sulfoximine; Cell Line; Cell Survival; Cricetinae; Cricetulus; Methionine Sulfoximine; Misonidazole; Oxygen; Radiation Tolerance; Radiation-Protective Agents; Radiation-Sensitizing Agents; Sulfhydryl Compounds | 1984 |
Tumor sensitization and protection: influence of stromal injury on estimates of dose modification.
Topics: Amifostine; Animals; Dose-Response Relationship, Radiation; Fibrosarcoma; Mice; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1984 |
Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721.
Topics: Amifostine; Animals; Body Weight; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukocyte Count; Male; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental | 1981 |
Modification of the oral radiation death syndrome with combined WR-2721 and misonidazole.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Mice; Mice, Inbred BALB C; Misonidazole; Mouth Mucosa; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Injuries, Experimental | 1981 |
Interaction of radiosensitizers and WR-2721. I. Modification of skin radioprotection.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Female; Lethal Dose 50; Mice; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Oxygen; Radiation Tolerance; Skin | 1982 |
The effect of misonidazole combined with WR2721 on tumour response and leucopenia due to cyclophosphamide or melphalan.
Topics: Amifostine; Animals; Cell Survival; Cyclophosphamide; Drug Therapy, Combination; Leukopenia; Melphalan; Mice; Mice, Inbred Strains; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental | 1982 |
Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.
Topics: Amifostine; Animals; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance; Sarcoma, Experimental | 1983 |
Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Topics: Amifostine; Animals; Cyclophosphamide; Drug Interactions; Drug Therapy, Combination; Extremities; Female; Fibrosarcoma; Lung Neoplasms; Male; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Time Factors | 1983 |
Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
Topics: Amifostine; Animals; Cell Line; Dose-Response Relationship, Drug; Drug Interactions; Female; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organothiophosphorus Compounds; Oxygen; Radiotherapy Dosage; Statistics as Topic | 1983 |
Modification of stromal radiosensitivity by misonidazole and WR-2721.
Topics: Adenocarcinoma; Amifostine; Animals; Connective Tissue; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance | 1983 |
Time dependence of interaction of misonidazole and WR-2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Fibrosarcoma; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Sarcoma, Experimental; Time Factors | 1983 |
[Combined use of amifostine and misonidazole in experimental radiotherapy].
Topics: Amifostine; Animals; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents | 1983 |
Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
Topics: Amifostine; Animals; Dose-Response Relationship, Radiation; Female; Kidney; Mice; Mice, Inbred CBA; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents; Radiation-Sensitizing Agents; Specific Pathogen-Free Organisms | 1983 |